Mira Pharmaceuticals (MIRA) Current Leases (2022 - 2024)

Mira Pharmaceuticals has disclosed Current Leases across 3 years of filings, most recently posting $1273.0 for Q1 2024.

• Current Leases for Q1 2024 came in at $1273.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $1273.0 (changed N/A YoY), and the FY2023 annual result was $5061.0, down 93.26% from the prior year.
• Current Leases came in at $1273.0 for Q1 2024 at Mira Pharmaceuticals, down from $5061.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $75362.0 in Q2 2023 to a low of $1273.0 in Q1 2024.
• The 3-year median for Current Leases is $74328.0 (2023), against an average of $46233.4.
• Peak annual rise in Current Leases reached 93.26% in 2023, while the deepest fall reached 93.26% in 2023.
• Mira Pharmaceuticals' Current Leases stood at $75143.0 in 2022, then sank by 93.26% to $5061.0 in 2023, then tumbled by 74.85% to $1273.0 in 2024.
• The last three Current Leases figures came in at $1273.0 (Q1 2024), $5061.0 (Q4 2023), and $74328.0 (Q3 2023), per Business Quant data.